News
The new agent upgrades the Databricks Assistant, enabling it to help data practitioners complete repetitive tasks and ...
Araclon linked the candidate to a 38% slowdown in disease progression compared to placebo in an exploratory analysis of phase 2 data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback